Immunosuppression: Clinical Trials

28 trials for Immunosuppression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 recruiting, 3 unknown, 2 not yet recruiting. 28 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 16, Recruiting 3, Unknown 3, Not yet recruiting 2, Terminated 2, Suspended 1, Withdrawn 1

Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thymalfasin for Immune Recovery in Adults With Sepsis
Thymalfasin (Thymosin alpha 1, Ta1) - Sepsis, Immunosuppression
Not applicableRecruitingShanghai Zhongshan Hospital602026-10-062026-10-08
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
HeartCare - Heart Transplant, Immunosuppression
Not applicableNot yet recruitingCareDx9302025-12-012024-10-23
Fibroscan to Guide Post Transplant Immunosuppression Minimization
Immunosuppression reduction - Immunosuppression
Not applicableRecruitingUniversity of Alberta502025-12-012026-01-08
Effect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation
Intervention group - Liver Transplant; Complications, Immunosuppression
Not applicableCompletedBitlis Eren University1402025-02-152026-02-25
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
Recombinant zoster vaccine adjuvanted (SHINGRIX) - Immunosuppression, Vaccine Response Impaired
Not applicableRecruitingCentral Adelaide Local Health Network Incorporated1602024-03-202026-04-09
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
Tacrolimus or Cyclosporine A - Immune Tolerance, Immunosuppression
Not applicableNot yet recruitingWei Gao472023-12-012023-11-27
Vascularized Composite Bladder Allograft Transplantation
Quality-of-Life Assessment, Robotic Vascularized Composite Bladder Allograft Transplantation - Neurogenic Bladder, Bladder Dysfunction
Not applicableSuspendedUniversity of Southern California52023-05-012026-06-18
ORCHARD- Optimising Home Assessment of Rural Patients
A sphygmanometer, a digital thermometer, a pulse oximeter and a peak flow meter will be given to participants to use during their telemedicine consultations with health care providers. - Organ Transplant, Cancer
Not applicableCompletedUniversity of Aberdeen122023-02-012025-03-30
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Access to Cue Health COVID-19 Remote testing and treatment for COVID-19 - Immunodeficiency, Immunosuppression
Not applicableTerminatedScripps Translational Science Institute21172022-12-222025-08-08
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
KidneyCare, steroid, MMF - Kidney Transplant, Immunosuppression
Not applicableWithdrawnCareDx2022-08-012023-03-27
Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test
TruGraf, Standard of Care - Kidney Transplant Rejection, Immunosuppression
Not applicableUnknownTransplant Genomics, Inc.752021-06-032021-08-27
Probiotics and Overreaching Recovery
probiotics, placebo - Fatigue; Muscle, Heart, Immunosuppression
Not applicableUnknownUniversity of Padova162021-06-012021-05-13
Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers
Modern acupuncture - Hepatocellular Cancer, Gastrointestinal Cancer
Not applicableCompletedTaipei Medical University WanFang Hospital52020-08-312020-12-31
Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial
Envarsus, Advagraf - Liver Transplant Rejection, Immunosuppression
Not applicableUnknownMedical University of Warsaw2002018-07-092018-07-27
Improvement of Postoperative Immunosuppression in Patients Receiving Coronary Artery Bypass Grafting by TEAS
TEAS+GA group, Sham TEAS+GA group - Immunosuppression
Not applicableCompletedShuGuang Hospital882017-12-012020-05-27
HFNC Alone or Associated With NIV for Immunocompromised Patients Admitted to ICU for Acute Respiratory Failure
NIV/HFNC, HFNC - Acute Respiratory Failure, Immunosuppression
Not applicableCompletedPoitiers University Hospital3002017-01-212019-09-04
Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
Tacrolimus, Prednisone, Mycophenolate mofetil - Immunosuppression
Not applicableCompletedMedical University of South Carolina402016-12-012019-12-24
Liver Immune Tolerance Marker Utilization Study
Controlled weaning of immunosuppression - Immunosuppression, Immune Tolerance
Not applicableCompletedUniversity of Toronto692015-04-012021-09-30
Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.
Arm A: Everolimus, Calcineurin Inhibitor - Immunosuppression, Renal Failure
Not applicableCompletedMilton S. Hershey Medical Center242013-12-162021-01-29
Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg
Tacrobell capsule 1mg, Prograf capsule 1mg - Immunosuppression
Not applicableCompletedChong Kun Dang Pharmaceutical502013-08-012014-07-23

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Neoplasms (2)  ·  Anemia, Sickle Cell (1)  ·  COVID-19 (1)  ·  Carcinoma, Hepatocellular (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Fatigue (1)  ·  Gastrointestinal Neoplasms (1)  ·  Graft vs Host Disease (1)  ·  HIV Infections (1)  ·  Hypoglycemia (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Influenza, Human (1)  ·  Leukemia (1)  ·  Liver Neoplasms (1)

Broader conditions

Infections (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urogenital Diseases (3)  ·  Behavior (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Glucose Metabolism Disorders (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)

Interventions

Tacrolimus (5)  ·  Mycophenolic Acid (4)  ·  Cyclosporine (2)  ·  Everolimus (2)  ·  Methylprednisolone (2)  ·  Adrenal Cortex Hormones (1)  ·  Alemtuzumab (1)  ·  Antilymphocyte Serum (1)  ·  Calcineurin Inhibitors (1)  ·  Cyclosporins (1)  ·  Influenza Vaccines (1)  ·  Islets of Langerhans Transplantation (1)  ·  Prednisone (1)  ·  Probiotics (1)  ·  Standard of Care (1)

Sponsors

CareDx (2)  ·  University of Pittsburgh (2)  ·  Bitlis Eren University (1)  ·  Central Adelaide Local Health Network Incorporated (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Emory University (1)  ·  Medical University of South Carolina (1)  ·  Medical University of Warsaw (1)  ·  Milton S. Hershey Medical Center (1)  ·  Northwestern University (1)  ·  Poitiers University Hospital (1)  ·  Scripps Translational Science Institute (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  Shanghai Zhongshan Hospital (1)  ·  ShuGuang Hospital (1)

Countries

United States (11)  ·  China (4)  ·  Canada (2)  ·  France (2)  ·  Australia (1)  ·  Poland (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Michael E de Vera, MD (2)  ·  Gary Levy, M.D. (1)  ·  Hongyu He (1)  ·  Hyeong Ki Lee, MD, Ph.D (1)  ·  Inderbir Gill (1)  ·  Jianggang Song, M.D. (1)  ·  Joseph Leventhal, MD (1)  ·  Luca Cicalese, MD (1)  ·  Meaghan MacArthur, M.Ed (1)  ·  Ming-Shun Wu, PHD (1)

Results publications

PMID 17645714, PMID 17889125, PMID 19459814, PMID 19502970, PMID 19638525, PMID 19857686, PMID 22996144, PMID 25393157, PMID 26227106, PMID 28941330, PMID 31615852, PMID 31888744, PMID 35020854, PMID 35325620, PMID 36094829, PMID 40503088, PMID 42335920

NIH funding

P30CA014089 (1), R01DK025243 (1)